Green Cross Medical Science Corporation Cash Flow Reinvestment Rate
Green Cross Medical Science Corporation cash flow reinvestment rate. Green Cross Medical Science Corporation (142280) has a Cash Flow Reinvestment Rate of 0.09x as of December 2025, reinvesting ₩460.89 Million (capex ₩460.89 Million ) from operating cash flow of ₩5.01 Billion. Explore 142280 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Green Cross Medical Science Corporation (2016–2025)
Cash flow reinvestment rate of Green Cross Medical Science Corporation from 2016 to 2025. Historical reinvestment intensity for Green Cross Medical Science Corporation across 6 annual periods. Explore Green Cross Medical Science Corporation capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Green Cross Medical Science Corporation Cash Flow Reinvestment Rate by Year (2016–2025)
Green Cross Medical Science Corporation cash flow reinvestment rate by year from 2016 to 2025. Year-by-year capital reinvestment analysis for Green Cross Medical Science Corporation. For the full cash flow conversion analysis, see 142280 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | ₩4.90 Billion | ₩7.20 Billion | ₩4.90 Billion | ▼ -61.5% |
| 2024 | 1.77x | ₩6.47 Billion | ₩3.66 Billion | ₩3.22 Billion | ▼ -20.7% |
| 2023 | 2.23x | ₩9.45 Billion | ₩4.24 Billion | ₩5.63 Billion | ▲ +311.2% |
| 2022 | 0.54x | ₩5.90 Billion | ₩10.88 Billion | ₩3.43 Billion | ▼ -0.8% |
| 2017 | 0.55x | ₩1.70 Billion | ₩3.11 Billion | ₩1.11 Billion | ▲ +106.8% |
| 2016 | 0.26x | ₩2.71 Billion | ₩10.25 Billion | ₩1.89 Billion | — |